| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-15 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-09 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |